BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15758433)

  • 1. Bone material properties and mineral matrix contributions to fracture risk or age in women and men.
    Burr DB
    J Musculoskelet Neuronal Interact; 2002 Mar; 2(3):201-4. PubMed ID: 15758433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.
    Seeman E
    Osteoporos Int; 2003; 14 Suppl 3():S2-8. PubMed ID: 12730770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased collagen organization and content are associated with reduced strength of demineralized and intact bone in the SAMP6 mouse.
    Silva MJ; Brodt MD; Wopenka B; Thomopoulos S; Williams D; Wassen MH; Ko M; Kusano N; Bank RA
    J Bone Miner Res; 2006 Jan; 21(1):78-88. PubMed ID: 16355276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineralization density distribution in health and disease.
    Roschger P; Paschalis EP; Fratzl P; Klaushofer K
    Bone; 2008 Mar; 42(3):456-66. PubMed ID: 18096457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls.
    Saito M; Fujii K; Marumo K
    Calcif Tissue Int; 2006 Sep; 79(3):160-8. PubMed ID: 16969591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cortical bone and its microstructure in bone strength.
    Augat P; Schorlemmer S
    Age Ageing; 2006 Sep; 35 Suppl 2():ii27-ii31. PubMed ID: 16926200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An expanded overview of postmenopausal osteoporosis.
    Marcus R
    J Musculoskelet Neuronal Interact; 2002 Mar; 2(3):195-7. PubMed ID: 15758431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Important determinants of bone strength: beyond bone mineral density.
    Friedman AW
    J Clin Rheumatol; 2006 Apr; 12(2):70-7. PubMed ID: 16601540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging concepts in osteoporosis and bone strength.
    Rubin CD
    Curr Med Res Opin; 2005 Jul; 21(7):1049-56. PubMed ID: 16004672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The degree of mineralization is a determinant of bone strength: a study on human calcanei.
    Follet H; Boivin G; Rumelhart C; Meunier PJ
    Bone; 2004 May; 34(5):783-9. PubMed ID: 15121009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related changes in porosity and mineralization and in-service damage accumulation.
    Norman TL; Little TM; Yeni YN
    J Biomech; 2008 Sep; 41(13):2868-73. PubMed ID: 18703196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new tool to assess the mechanical properties of bone due to collagen degradation.
    Wynnyckyj C; Omelon S; Savage K; Damani M; Chachra D; Grynpas MD
    Bone; 2009 May; 44(5):840-8. PubMed ID: 19150659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
    Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone matrix quality and plasma homocysteine levels.
    Blouin S; Thaler HW; Korninger C; Schmid R; Hofstaetter JG; Zoehrer R; Phipps R; Klaushofer K; Roschger P; Paschalis EP
    Bone; 2009 May; 44(5):959-64. PubMed ID: 19168164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from the European Prospective Osteoporosis Study.
    Kaptoge S; Benevolenskaya LI; Bhalla AK; Cannata JB; Boonen S; Falch JA; Felsenberg D; Finn JD; Nuti R; Hoszowski K; Lorenc R; Miazgowski T; Jajic I; Lyritis G; Masaryk P; Naves-Diaz M; Poor G; Reid DM; Scheidt-Nave C; Stepan JJ; Todd CJ; Weber K; Woolf AD; Roy DK; Lunt M; Pye SR; O'neill TW; Silman AJ; Reeve J
    Bone; 2005 Mar; 36(3):387-98. PubMed ID: 15777673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?
    Seeman E
    Bone; 2007 Sep; 41(3):308-17. PubMed ID: 17644058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low width of tubular bones is associated with increased risk of fragility fracture in elderly men--the MINOS study.
    Szulc P; Munoz F; Duboeuf F; Marchand F; Delmas PD
    Bone; 2006 Apr; 38(4):595-602. PubMed ID: 16249130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of bone mineral density, bone turnover, and other properties in reducing fracture risk during antiresorptive therapy.
    Epstein S
    Mayo Clin Proc; 2005 Mar; 80(3):379-88. PubMed ID: 15757020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomechanical effects of inflammatory diseases on bone-rheumatoid arthritis as a paradigm.
    Abdulghani S; Caetano-Lopes J; Canhão H; Fonseca JE
    Autoimmun Rev; 2009 Jul; 8(8):668-71. PubMed ID: 19223022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of risedronate on bone mineralization as measured by micro-computed tomography with synchrotron radiation: correlation to histomorphometric indices of turnover.
    Borah B; Ritman EL; Dufresne TE; Jorgensen SM; Liu S; Sacha J; Phipps RJ; Turner RT
    Bone; 2005 Jul; 37(1):1-9. PubMed ID: 15894527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.